Clinical Trial Update: Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma [Phase 1]

View source ↗

Summary

This Phase 1 trial investigates nivolumab with or without stereotactic radiosurgery for chordoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Chordoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING